title: IL1 blockade in crystal-induced arthritis: impact of disease duration and the inflammatory syndrome. Comments on the article by Couderc M. et al. "Efficacy of anakinra in articular chondrocalcinosis".
authors.forename: Frank
authors.initials: F
authors.lastname: Verhoeven
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
authors.forename: Marie
authors.initials: M
authors.lastname: Godfrin-Valnet
authors.forename: Xavier
authors.initials: X
authors.lastname: Guillot
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002805:Chondrocalcinosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein